Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo.
about
Obstructive sleep apnea syndrome and fatty liver: association or causal link?Obstructive sleep apnea as a risk factor for type 2 diabetes mellitusInsulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoeaPathophysiology of sleep apneaSuicidal gene therapy in an NF-κB-controlled tumor environment as monitored by a secreted blood reporterSLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELSCPAP versus oxygen in obstructive sleep apneaIs C-reactive protein a marker of obstructive sleep apnea?: A meta-analysisIntermittent hypoxia: cause of or therapy for systemic hypertension?Molecular biomarkers of vascular dysfunction in obstructive sleep apnea.Hypoxia. 4. Hypoxia and ion channel functionNocturnal hypoxia in ALS is related to cognitive dysfunction and can occur as clusters of desaturations.Endothelial function in obstructive sleep apnea.Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome.Obstructive sleep apnea, inflammation, and the metabolic syndromeEffects of prolonged exposure to hypobaric hypoxia on oxidative stress, inflammation and gluco-insular regulation: the not-so-sweet price for good regulation.Mechanisms and clinical consequences of untreated central sleep apnea in heart failureIntermittent Hypoxia Alters Gene Expression in Peripheral Blood Mononuclear Cells of Healthy Volunteers.The effect of acute intermittent hypercapnic hypoxia treatment on IL-6, TNF-alpha, and CRP levels in piglets.Oxidative stress and quality of life in elderly patients with obstructive sleep apnea syndrome: are there differences after six months of Continuous Positive Airway Pressure treatment?Transcriptional responses to intermittent hypoxiaMetabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanismsObstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approachesSimulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver.Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more.Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndromeVascular inflammation and sleep disordered breathing in a community-based cohortCan high altitude influence cytokines and sleep?The association between sleep-disordered breathing and aortic stiffness in a community cohort.The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition.Inflammation and oxidative stress in obstructive sleep apnea syndrome.Post-translational modification of proteins during intermittent hypoxia.Mechanisms of endothelial dysfunction in obstructive sleep apnea.Molecular signatures of obstructive sleep apnea in adults: a review and perspective.Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarctionA pro-inflammatory role for nuclear factor kappa B in childhood obstructive sleep apnea syndromeCan O2 dysregulation induce premature aging?PPAR-gamma expression in animals subjected to volume overload and chronic Urotensin II administration.Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.Metabolic consequences of sleep-disordered breathing.
P2860
Q24612841-D74B345F-5753-4ABD-A5EA-6C30C6F89189Q26778430-DDAFD41B-0197-401E-9535-4513E81D001EQ26783727-42E0091C-15E2-4811-9629-A46214B53ACDQ30440658-AF385A71-C57C-4AA4-AA4E-37E9A43E2E25Q30449201-EC578BFA-735F-40CE-9573-3B56059E033EQ30494316-4FDCE157-C45D-46B3-A937-3DBBC01FA1B9Q30587460-6CBCA629-E9C2-4FEE-AA4E-975FF4B8FA6FQ33672788-C8C25D74-E141-45B5-9A73-95CFEC2EA727Q34769610-04B1E132-57D2-4413-86D2-DDC93885D0F6Q34907105-B95B9089-E753-4EC1-B31D-5D0CD84E0A4AQ34979263-F8606EFF-71B1-441B-8F27-78B6998EBDCBQ34995040-012D9E22-80E1-4358-80EF-4465BE42EFF6Q35086889-28E853A5-389B-4E6E-B8BA-62B3A5F907EEQ35092244-6801BD8C-01D1-47C1-B00D-544D0CFFA291Q35104040-9EDB1ABD-CCD9-454E-92E5-4F195324FB52Q35148111-4948418C-FD19-4FD2-B914-CBF41847575FQ35335969-7F6BC7A1-15C7-401E-BC3D-DDF9ECF7639FQ35866630-21309C32-9978-4A03-A47E-EED3D742A7D9Q35995471-1BB2ABCB-D98C-45CA-BC83-CBD295CB3B90Q36017234-BE6B0B9F-6D9F-4548-BCE0-25CAE8231438Q36079641-8FFB9FE5-A4B6-488D-B0AF-BD313A82BBEEQ36093354-CF48D2C5-FECD-4A43-873F-DDD3D3BB8BF9Q36396309-06E93CAF-E334-4F9C-8053-3790932199A4Q36443187-AC9FF03F-7663-4636-95FD-0441E3B2A2CEQ36482623-CD4BCC0D-AB15-464F-9BCE-3B87AF7B9265Q36537445-41531F3B-0022-4150-9171-B446A5603A80Q36755615-77F50995-C3B5-493A-8427-BC90E88C4BCAQ36831048-76376831-2B5D-450F-9FB5-F5F0BF9E2FCBQ36923176-3F3E190B-883F-4E64-B753-ABEACEFED69CQ36990311-4A0BE63E-45A1-41C4-95F3-7A150E6FBA2CQ37015165-8A482391-0E35-4CAD-B4A3-C3604347E166Q37097673-F2EE16AA-0D43-495E-A9DF-683A79B18930Q37145667-38AD1ADA-47CA-44C6-9970-86A5DE3C4C2CQ37146506-85955008-FD17-4FC7-8A58-2A3982412F94Q37167471-C01509DD-5D42-47E7-BFE4-08CB4BBBD335Q37301940-406678FB-55A4-4D71-A087-4CD0D270B354Q37346880-2F35AAA4-ACAF-45CF-B7C8-0EF7E09A5DB9Q37422701-9E85B298-49B5-4FEE-80D4-ACF0F5530CCEQ37464853-74A032E5-0528-49F2-B816-F14351271D4CQ37511434-3B80D395-DEB3-40CF-A49A-A03E77769269
P2860
Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@ast
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@en
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@nl
type
label
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@ast
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@en
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@nl
prefLabel
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@ast
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@en
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@nl
P2093
P1476
Chronic intermittent hypoxia a ...... ardiovascular tissues in vivo.
@en
P2093
Aung K Htoo
David Wilson
Harly Greenberg
Shu Fang Liu
Todd Hendersen
Xiaobing Ye
P304
P356
10.1016/J.BBRC.2006.03.015
P407
P577
2006-03-13T00:00:00Z